MOD I Medications Flashcards
Ipratropium Bromide Dosages
-Adult: .5mg via handheld neb
Duoneb with 2.5mg albuterol No repeat dose-
Pediatric(Over 2/20kg) .5mg w/ 2.5mg Albuterol
Duoneb(Under 2/20kg) .25mg w/ 1.25mg Albuterol
Ipratropium Bromide Classification & MoA
Classifications:
Anti Cholinergic
Bronchodilator
MoA
Inhibits interaction of acetylcholine at receptor site on bronchial smooth muscle.
Ipratropium Bromide Indications, Contraindications, adverse effects
Indications:
Bronchial Asthma, COPD, Emphysema, Chronic Bronchitis, Anaphylaxis, Burns, Toxic Inhalation
Contraindication:
Hypersensitivity
Adverse Effects
Tachycardia, Nausea/vomiting, headache, blurred vision
Albuterol Classifications / MoA
Classifications:
Beta2 Agonist, Sympathomimetic Bronchodilator
MoA
Relaxes bronchial smooth muscle but stimulating Beta2 receptors resulting in bronchodilation and decreased airway resistance.
Albuterol Indications, Contraindications, Adverse Effects
Indications:
Bronchial Asthma, COPD/Emphysema/Chronic Bronchitis, Bronchospasm due to Anaphylaxis, burns, toxic inhalation, crush syndrome > 4 hours
Contraindications:
Tachydysrhythmias
Adverse Effects:
Tachycardia, Anxiety, Dysrhythmias, throat irritation, tremors, palpations, dry mouth
Albuterol Dosages
- Adult:
2. 5MG-5MG via handheld Neb
Duoneb with .5mg Atrovent -Pediatric (>2/20kg) 2.5mg via Neb Duoneb with .5mg Atrovent -Pediatric (<2/20kg) 1.25mg via Neb Duoneb with .25mg Atrovent
Ondansetron Classifications / MoA
Classification: Antiemetic
MoA: Selective 5-HT3 Serotonin receptor antagonist
Ondansetron Indications / Contraindications
Indications: Control / prevent nausea & vomiting
Contraindications:
Prolonged QT Syndrome
Ondansetron Adverse Effects / Dosages
Adverse Effects: GI Symptoms, Headache,Fever,Blurred Vision, Chest Pain, EKG Changes
Dosages: -Adult: 4mg undiluted slow IV / 4mg ODT Tablet -Pediatric 0.1mg/kg slow IV max 4mg Over 2/20kg 4mg tablet ODT Under 2/20kg 2mg Tablet ODT
Naloxone Classification / MoA/ Pharm
Classification : Narcotic Antagonist
MoA: Reverses all effects due to opioid agents. Reverses respiratory depression and all CNS PNS system effects.
Pharm: Onset within few minutes via IV
IM/ET results in slower onset of action
Naloxone Indications/Contraindications/ Adverse Effects
Indications:
Reverse respiratory and CNS System depression induced by opiates
Contraindications:
Newborns / neonates of addicted mothers.
Adverse Effects:
NONE
Naloxone Dosages
-Adult:
.4mg - 2mg IV/IO/IM or 2mg in 2ml IN, Repeat as necessary to maintain respiratory activity.
-Pediatric:
.1mg/kg IVP/IO/IM/IN up to max initial dose of 2mg, Max of .5mg/kg total dose.
Magnesium Sulfate Classifications
Electrolyte, Antidysrhythmic, Anticonvulsant, CNS Depressant, Smooth Muscle Relaxant
Magnesium Sulfate MoA
As antidysrhythmic, Magnesium sulfate is a physiological calcium channel blocker reducing SA Node impulse formation and prolongs conduction time in the myocardium.
As anticonvulsant, Magnesium sulfate redusces striated muscle contractions and blocks peripheral neuromuscular transmission by reducing acetylcholine release at the myoneural junction.
Magnesium Sulfate Indications / Contraindications
Indications:
Preeclampsia/eclampsia, Torsades des Pointes, Refractory Ventricular Fibrillation, Pulseless Ventricular Tachycardia with suspected hypomagnesemia, Status asthmaticus
Contraindications:
Myasthenia Gravis, Impaired renal function